Mar 15, 2022 / 01:00PM GMT
Huidong Wang - Barclays Bank PLC, Research Division - Research Analyst
Okay. Great. My name is Gena Wang. I'm speaking of biotech analyst at the Barclays. Thank you for coming to our first in-person Global Healthcare Conference post pandemic. It is really nice to see everyone in person. I wanted to thank everyone, investors, companies, especially (inaudible) team who made this event possible.
With that, it's my great pleasure to introduce our next presenting company, Intellia. With us today, we have John Leonard, President and Chief Executive Officer.
John, do you want to give a very brief introduction before we dive into the questions?
John M. Leonard - Intellia Therapeutics, Inc. - President, CEO & Director
Sure. Sure. Thank you. I can -- real quickly I can kind of lay out what Intellia is. We call ourselves a full spectrum (inaudible) company, which means we have really 3 legs to the stool, a very, very active in vivo effort where we emphasize systemically administered CRISPR/Cas9. I'm sure we'll be talking about that.
We also
Intellia Therapeutics Inc at Barclays Global Healthcare Conference Transcript
Feb 08, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers